Literature DB >> 6097160

Steroid receptors in breast cancer in Indian women.

R Seshadri, P N Shah.   

Abstract

The distribution of receptors for estradiol (ER), progesterone (PgR) and androgens (DHTR) in 104 primary and 49 metastatic breast tumours from Indian women is herein being reported for the first time. When compared to reports in the literature, a lower percentage (47%) of ER (+) tumours and a higher percentage (49%) of DHTR (+) tumours were observed. There were more ER (-) tumours in premenopausal as compared to postmenopausal women, and more ER (-) tumours had lymph node metastases at the time of surgery. Both these correlations were statistically significant.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6097160

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Cinical Significance of Androgen Receptor, CK-5/6, KI-67 and Molecular Subtypes in Breast Cancer.

Authors:  Münire Kayahan; Ufuk Oğuz İdiz; Zuhal Gucin; Fazilet Erözgen; Naim Memmi; Mahmut Müslümanoğlu
Journal:  J Breast Health       Date:  2014-10-01

2.  Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S.--a SEER analysis.

Authors:  Madhuri Kakarala; Laura Rozek; Michele Cote; Samadhi Liyanage; Dean E Brenner
Journal:  BMC Cancer       Date:  2010-05-11       Impact factor: 4.430

3.  Breast cancer prognosis in three different racial groups in relation to steroid hormone receptor status.

Authors:  R J Pegoraro; D Nirmul; S G Reinach; J P Jordaan; S M Joubert
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

4.  Expression of androgen receptor in breast cancer & its correlation with other steroid receptors & growth factors.

Authors:  Ashwani K Mishra; Usha Agrawal; Shivani Negi; Anju Bansal; R Mohil; Chintamani Chintamani; Amar Bhatnagar; Dinesh Bhatnagar; Sunita Saxena
Journal:  Indian J Med Res       Date:  2012-06       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.